Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
Breast Cancer Awareness month will soon be coming to a close, but that does not mean radiology practices and breast imaging centers should relax the attention they pay to patients who come in for breast cancer screening. This week, Diagnostic Imaging spoke with breast imaging technologist Stephanie Johnston from Solis Mammography in Texas about what is most important to women when they come in for annual screening, as well as what practices can do to ensure women have the best counters possible.
For additional insights on patient experience, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Stroke remains the leading cause of disability in the United States, as well as a leading cause of death. Given their skill set, radiologists are uniquely positioned for stroke prevention. In a column this week, Diagnostic Imaging Editorial Board member Mina Makary, M.D., an interventional radiologist from The Ohio State University Wexner Medical Center, shared insights on alternative training models for interventional neuroradiology.
To read our previous coverage of neuroimaging, click here.
Research efforts are continuing to help providers better understand the development of dementia in patients. This week, we will share investigation results from two institutions that shed light on how this disease affects the brain. Look for this coverage as the week progresses.
To read Diagnostic Imaging’s dementia coverage, click here.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).